SCHEMBL4964356

SCHEMBL4964356

Cc1cc(Cl)ccc1-c1cc(Cl)cc2c1OC(CN)O2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AQP1 P29972 2/20 0.38
NOTUM Q6P988 2/20 0.35
GRM2 Q14416 1/20 0.33
GPBAR1 Q8TDU6 1/20 0.33
S1PR2 O95136 1/20 0.33
S1PR4 O95977 1/20 0.33
S1PR1 P21453 1/20 0.33
S1PR5 Q9H228 1/20 0.33
SLC1A3 P43003 1/20 0.32
SLC1A2 P43004 1/20 0.32
SLC1A1 P43005 1/20 0.32
NPC1 O15118 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CA2 P00918 2/20 0.32
CA1 P00915 1/20 0.32
BRD4 O60885 1/20 0.31
PTGDR2 Q9Y5Y4 1/20 0.31
S100A4 P26447 1/20 0.31
NR3C1 P04150 1/20 0.31
PGR P06401 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4961054 0.86 GPBAR1 (0.36) GPBAR1NPC1
SCHEMBL6105035 0.86 AQP1 (0.47) AQP1S100A4CYP3A4
SCHEMBL4964618 0.85 AQP1 (0.37) AQP1S1PR2S1PR4S1PR1S1PR5
SCHEMBL4960246 0.82 AQP1 (0.44) AQP1NOTUMNPC1L3MBTL1CA2
SCHEMBL6104331 0.82 ALDH1A1 (0.40) NPC1L3MBTL1SMN1; SMN2
SCHEMBL6104448 0.79 DPP4 (0.40) AQP1
SCHEMBL4964371 0.77 NOTUM (0.35) AQP1NOTUMNPC1L3MBTL1NR3C1
SCHEMBL4960468 0.76 PTGDR2 (0.36) PTGDR2PGRMAPTCYP3A4
SCHEMBL8225917 0.76 PTGS1 (0.39) PTGDR2
SCHEMBL4961611 0.76 AQP1 (0.38) AQP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1871759-A1 BENZODIOXANE AND BENZODIOXOLANE DERIVATIVES AND USES THEREOF Wyeth a Corporation of the State of Delaware (US) 2008-01-02 EP disclosed
WO-2006116158-A1 BENZODIOXANE AND BENZODIOXOLANE DERIVATIVES AND USES THEREOF WYETH (US) 2006-11-02 WO disclosed
US-20060241172-A1 Benzodioxane and benzodioxolane derivatives and uses thereof WYETH (US) 2006-10-26 US disclosed
US-20060241172-A1 Benzodioxane and benzodioxolane derivatives and uses thereof WYETH (US) 2006-10-26 US disclosed
US-20060241172-A1 Benzodioxane and benzodioxolane derivatives and uses thereof WYETH (US) 2006-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241172-A1 Benzodioxane and benzodioxolane derivatives and uses thereof HTR2C, HTR1D, HTR1A AQP1 1697/4885NOTUM 3276/4885GRM2 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.